Efficacy of Quetiapine in Generalised Social Anxiety Disorder
Status and phase
Terminated
Phase 3
Conditions
Social Anxiety Disorder
Treatments
Drug: quetiapine
Details and patient eligibility
About
This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with the LSAS
Enrollment
50 estimated patients
Sex
All
Ages
18 to 65 years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Written Confirmed Consent,
- All patients meet the DSM IV criteria for generalized social anxiety disorder,
- A score ≥ 60 on the LSAS,
- male and female aged between 18 and 65 years
Exclusion criteria
- Presence of any primary axis I diagnosis other than social anxiety disorder according to DSM-IV,
- alcohol and/or substance abuse according to DSM-IV criteria within the last 12 months,
- any personality disorder as the primary diagnosis, with the exception of avoidant personality disorder,
- patients at risk of suicide
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Parallel Assignment
Masking
Double Blind
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems